-

Trividia Health Announces Jonathan Chapman as President and Chief Executive Officer

Effective immediately, adds proven record of global leadership and demonstrated success

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Trividia Health, Inc., a leading supplier of blood glucose monitoring systems, announced today that Jonathan Chapman has been appointed as President and Chief Executive Officer. Mr. Chapman succeeds Scott Verner in the role.

Mr. Chapman brings over 20 years of leadership experience in the medical device industry, with an accomplished track record of driving growth, developing strategic alliances, launching products globally, and optimizing business operations.

In addition to his newly assumed responsibilities at Trividia Health, Mr. Chapman will continue to serve as President and Chief Executive Officer of PTS Diagnostics, Inc.

“Jonathan has proven himself as the right leader for PTS Diagnostics and is the right leader for Trividia,” said Shaobo Li, Chairman of the Board at both Trividia Health and PTS Diagnostics. “Jonathan’s extensive background in successfully running medical device companies and his business development skills will help both organizations to reach the next level of growth and evolution. Jonathan is a results-oriented, dynamic, and innovative business leader. I am confident he has the right track record, commitment, vision and judgment to lead Trividia and PTS Diagnostics.”

“I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes,” said Jonathan Chapman, President and CEO of Trividia Health and PTS Diagnostics. “I look forward to working with my colleagues at Trividia. With their support, focus on customers and continuing dedication, we will build on Trividia’s legacy of bringing leading innovation to patients across the globe.”

Mr. Chapman received a Bachelor of Arts from Sheffield University UK, LLM Commercial and Corporate Law from University of London (SOAS) and LLM Health Law from Hamline Law School, St. Paul, MN. Trividia is confident that his international experience will be immensely valuable when leading the organization across global markets.

About Trividia Health

Trividia Health, Inc., is a global health and wellness company with over 30 years experience in the industry. Based in Fort Lauderdale, Florida, Trividia is a leading developer, manufacturer and marketer of advanced performance products for people and pets with diabetes. With products sold under the TRUE brand, store brand labels and Healthy Tracks for Pets, the company is the exclusive partner and supplier of affordable, high-quality blood glucose monitoring and health and wellness solutions for the world’s leading retail pharmacies, distributors and mail service providers. For more information, please visit: www.TrividiaHealth.com.

Contacts

Neal Bhattacharya, Sr. Director, Product Marketing
(800) 342-7226, ext. 3150 – nbhattacharya@trividiahealth.com

Industry:

Trividia Health, Inc.

Release Versions
EnglishSpanishPortugueseGermanFrenchItalian (Summary)Dutch (Summary)Chinese TraditionalChinese SimplifiedJapanese

Contacts

Neal Bhattacharya, Sr. Director, Product Marketing
(800) 342-7226, ext. 3150 – nbhattacharya@trividiahealth.com

More News From Trividia Health, Inc.

Trividia Health, Inc. Announces Preferred Listing of the TRUE METRIX® Blood Glucose Meters and Test Strips on the Express Scripts Commercial National Preferred Formulary

FT. LAUDERDALE, Fla.--(BUSINESS WIRE)--Trividia Health, Inc., announced today that it’s TRUE METRIX® Self-Monitoring Blood Glucose Systems are preferred for commercial patients on the Express Scripts National Preferred Formulary in the United States, effective October 1st, 2025. The TRUE METRIX® portfolio provides a level of performance rooted in science, research and technological advancements. TRUE METRIX test strips feature TRIPLE SENSE TECHNOLOGY®, which ensures proven accuracy and confiden...

Trividia Health, Inc. Announces Preferred Listing of the TRUE METRIX® Blood Glucose Systems on CVS Caremark Commercial Template Formularies

FT. LAUDERDALE, Fla.--(BUSINESS WIRE)--Trividia Health, Inc., announced today that it’s TRUE METRIX® Self-Monitoring Blood Glucose Systems are now preferred for commercial patients on CVS Caremark Commercial Template Formularies in the United States, replacing OneTouch® branded blood glucose monitors and test strips. The TRUE METRIX® portfolio delivers scientifically backed performance built on decades of research and technological innovation. The TRUE METRIX meters and test strips feature TRIP...

Trividia Health, Inc. Initiates Voluntary Recall of Limited Number of TRUE METRIX® Blood Glucose Meters

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Trividia Health, Inc., announced today that it is initiating a voluntary recall of a limited number of TRUE METRIX® Self-Monitoring Blood glucose meters co-branded under the Good Neighbor Pharmacy® brand and distributed in the United States. The company has determined that 601 TRUE METRIX® Meters, lot number KD0746, manufactured September 4, 2025 and distributed September 8, 2025, through September 16, 2025, may have the potential for defective LCD displa...
Back to Newsroom